AU2001292943A1 - Prevention and treatment of streptococcal and staphylococcal infection - Google Patents

Prevention and treatment of streptococcal and staphylococcal infection

Info

Publication number
AU2001292943A1
AU2001292943A1 AU2001292943A AU9294301A AU2001292943A1 AU 2001292943 A1 AU2001292943 A1 AU 2001292943A1 AU 2001292943 A AU2001292943 A AU 2001292943A AU 9294301 A AU9294301 A AU 9294301A AU 2001292943 A1 AU2001292943 A1 AU 2001292943A1
Authority
AU
Australia
Prior art keywords
streptococcal
prevention
treatment
staphylococcal infection
staphylococcal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292943A
Inventor
Colette Cywes
Michael R. Wessels
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Brigham and Womens Hospital Inc
Original Assignee
Brigham and Womens Hospital Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham and Womens Hospital Inc filed Critical Brigham and Womens Hospital Inc
Publication of AU2001292943A1 publication Critical patent/AU2001292943A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
AU2001292943A 2000-09-21 2001-09-21 Prevention and treatment of streptococcal and staphylococcal infection Abandoned AU2001292943A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23414500P 2000-09-21 2000-09-21
US60234145 2000-09-21
PCT/US2001/029636 WO2002024223A2 (en) 2000-09-21 2001-09-21 Prevention and treatment of streptococcal and staphylococcal infection

Publications (1)

Publication Number Publication Date
AU2001292943A1 true AU2001292943A1 (en) 2002-04-02

Family

ID=22880130

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292943A Abandoned AU2001292943A1 (en) 2000-09-21 2001-09-21 Prevention and treatment of streptococcal and staphylococcal infection

Country Status (3)

Country Link
US (1) US20020055488A1 (en)
AU (1) AU2001292943A1 (en)
WO (1) WO2002024223A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7238677B2 (en) 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
UY30776A1 (en) * 2006-12-21 2008-07-03 Medarex Inc CD44 ANTIBODIES
US10696722B2 (en) 2016-08-10 2020-06-30 Ajou University Industry-Academic Cooperation Foundation Heterodimeric Fc-fused cytokine and pharmaceutical composition comprising the same
PE20211279A1 (en) 2018-10-23 2021-07-19 Dragonfly Therapeutics Inc HETERODIMERIC PROTEINS FUSED WITH FC
KR20230004746A (en) 2020-04-22 2023-01-06 드래곤플라이 쎄라퓨틱스, 인크. Formulations, dosing regimens and manufacturing methods for heterodimeric FC-fusion proteins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3310994B2 (en) * 1991-07-03 2002-08-05 電気化学工業株式会社 Allergy treatment
JPH06107550A (en) * 1992-09-29 1994-04-19 Yutaka Kurachi Anti-inflammatory agent for oral administration

Also Published As

Publication number Publication date
WO2002024223A3 (en) 2002-06-06
US20020055488A1 (en) 2002-05-09
WO2002024223A2 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
IL148641A0 (en) Topical treatment of streptococcal infections
MXPA03003168A (en) Topical antibiotic composition for treatment of eye infection.
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
EP1162994A4 (en) A means for the prophylactic and therapeutic treatment of streptococcal infections
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
AU2002356868A1 (en) Methods for the prevention or treatment of bacterial and fungal infections
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU2002246545A1 (en) Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes
AU6887101A (en) Copolymers and methods of treating prion-related diseases
AU1572101A (en) Admixture of linezolid and other antibacterial agents
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU2001257163A1 (en) Glycopeptide antibacterial compounds and methods of using same
AU2001292943A1 (en) Prevention and treatment of streptococcal and staphylococcal infection
AU2001286852A1 (en) Quinoline antibacterial compounds and methods of use thereof
AU2002367861A1 (en) Prevention and treatment of streptococcal and staphylococcal infection
AU2001245414A1 (en) Treatment of allergies
AU1923501A (en) Pyridinones to treat and prevent bacterial infections
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2001296253A1 (en) Antibacterial agents and methods of identification
AU2001282277A1 (en) Treatment of mycobacterial infection
AU1392601A (en) Prevention and treatment of biomaterial-associated infections
AU2001267177A1 (en) Diagnosis and treatment of herpes infections
AU4683299A (en) Detection of streptococcus pneumoniae and immunization against streptococcus pneumoniae infection
AU2002350565A1 (en) Pharmacological targeting of bacterial dna ligase for treatment and prevention of bacterial infections